Initially funded by the Canceropôle PACA, the CRISPR screen platform enables genome-wide interrogation of the functional consequences of genomic or epigenomic alterations in coding and regulatory regions, revealing how genomic modifications lead to phenotypic changes.
LabCom DECIPHER: https://www.decipher-labcom.fr
Team Members:
Salvatore Spicuglia
Iris Manosalva
External collaborators:
Sandrine Roulland – CIML, Marseille
Bernard Mari – IPMC, Sophia-Antipolis
Els Verhoeyen – C3M, Nice
Industrial partner:
AdvancesBiodesign (ABD): https://a-biodesign.com